Arrowhead Pharmaceuticals, Inc. (ARWR) vs Praxis Precision Medicines, Inc. (PRAX)
- Arrowhead Pharmaceuticals, Inc. ARWR 55.90 −4.44%
- Praxis Precision Medicines, Inc. PRAX 241.76 −2.61%
Arrowhead Pharmaceuticals, Inc. and Praxis Precision Medicines, Inc. are both Biotechnology companies. Arrowhead Pharmaceuticals, Inc. is the larger, with a market value of $8.3B against $6.9B — 1.2× the size. Praxis Precision Medicines, Inc. grew revenue faster over the last twelve months: 249.5% against 16.1%. Praxis Precision Medicines, Inc. has the higher net margin (0.00% vs −47.8%) and the lower return on invested capital (−40.6% vs 0.00%). Across the 16 metrics below, Arrowhead Pharmaceuticals, Inc. leads on 8 and Praxis Precision Medicines, Inc. on 8.
Valuation
Profitability
| Metric | ARWR | PRAX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (33.82%) | 0.00% | 0.00% |
| Net margin | (47.79%) | 0.00% | 0.00% |
| Free cash flow margin | (11.22%) | 0.00% | 0.00% |
| Return on equity | (64.91%) | (38.86%) | (56.36%) |
| Return on assets | (18.32%) | (36.80%) | (48.04%) |
| Return on invested capital | 0.00% | (40.58%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack